Evaluation of the effect of smokeless tobacco purified products and extracts on latent Epstein-Barr virus

Toxicology

Volumn 133, Issue 1, 1999, Pages 35-42

  Jenson, Hal B ^a   Heard, Patty ^a   Moyer, Mary Pat ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

12 O tetradecanoyl phorbol 13 acetate; Epstein Barr virus; Fluorescence activated cell sorter flow cytometry; n Butyrate; Smokeless tobacco; Virus induction

Indexed keywords

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUTH CANCER; PRIORITY JOURNAL; RAJI CELL; SMOKELESS TOBACCO; VIRUS CARCINOGENESIS; VIRUS REPLICATION;

BENZO(A)PYRENE; CELL LINE; CELL SURVIVAL; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; NITROSAMINES; PLANT EXTRACTS; PLANTS, TOXIC; TETRADECANOYLPHORBOL ACETATE; TOBACCO, SMOKELESS; VIRUS ACTIVATION;

ANIMALIA; HUMAN HERPESVIRUS 4; NICOTIANA TABACUM;

EID: 0032927292     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(99)00003-7     Document Type: Article

References (39)

1. Boos H., Berger R., Kuklik-Roos C., Iftner T., Mueller-Lantzsch N. Enhancement of Epstein-Barr virus membrane protein (LMP) expression by serum, TPA, or n-butyrate in latently infected Raji cells. Virology. 159:1987;161-165.
2. Bouvier G., Poirier S., Shao Y.M., Malaveille C., Ohshima H., Polack A., Bornkamm G.W., Zeng Y., de-Thé G., Bartsch H. Epstein-Barr virus activators, mutagens and volatile nitrosamines in preserved food samples from high-risk areas for nasopharyngeal carcinoma. IARC Sci. Publ. 105:1991;204-209.
3. Chang R.S., Lewis J.P., Abildgaard C.F. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. New Engl. J. Med. 289:1973;1325-1329.
4. Chang R.S., Lewis J.P., Reynolds R.D., Sullivan M.J., Neuman J. Oropharyngeal excretion of Epstein-Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann. Intern. Med. 88:1978;34-40.
5. D'Costa J., Saranath D., Sanghvi V., Mehta A.R. Epstein-Barr virus in tobacco-induced oral cancers and oral lesions in patients from India. J. Oral Pathol. Med. 27:1998;78-82.
6. Epstein M.A., Achong B.G., Barr Y.M., Zajac B., Henle G., Henle W. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J. Natl. Cancer Inst. 37:1966;547-559.
7. Ferbas J., Rahman M.A., Kingsley L.A., Armstrong J.A., Ho M., Zhou S.Y.J., Rinaldo C.R. Jr. Frequent oropharyngeal shedding of Epstein-Barr virus in homosexual men during early HIV infection. AIDS. 6:1992;1273-1278.
8. Gerber P. Activation of Epstein-Barr virus by 5-bromodeoxyuridine in 'virus-free' human cells. Proc. Natl. Acad. Sci. U.S.A. 69:1972;83-85.
9. Gupta P., Singh M.K., Rinaldo C., Ding M., Farzadegan H., Saah A., Hoover D., Moore P., Kingsley L. Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma. AIDS. 10:1996;1596-1598.
10. Hampar B., Derge J.G., Martos L.M., Walker J.L. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Proc. Natl. Acad. Sci. U.S.A. 68:1971;3185-3189.
11. Hayashi K. Effect of protein kinase C inhibitors with different action mechanisms on Epstein-Barr virus replication. Intervirology. 33:1992;217-224.
12. Hecht S.S., Rivenson A., Braley J., DiBello J., Adams J.D., Hoffmann D. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46:1986;4162-4166.
13. Henle W., Henle G., Zajac B.A., Pearson G., Waubke R., Scriba M. Differential reactivity of human serums with early antigens induced by Epstein-Barr virus. Science. 169:1970;188-190.
14. Hoffmann D., Djordjevic M.V. Chemical composition and carcinogenicity of smokeless tobacco. Adv. Dent. Res. 11:1997;322-329.
15. Hoffmann D., Rivenson A., Chung F.L., Hecht S.S. Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Crit. Rev. Toxicol. 21:1991;305-311.
16. Hoffmann D., Brunnemann K.D., Prokopczyk B., Djordjevic M.V. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health. 41:1994;1-52.
17. Ito Y., Yanase S., Fujita J., Harayama T., Takashima M., Imanaka H. A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus. Cancer Lett. 13:1981;29-37.
18. Jenson H.B., Grant G.M., Ench Y., Heard P., Thomas C.A., Hilsenbeck S.G., Moyer M.P. Immunofluorescence microscopy and flow cytometry characterization of chemical induction of latent Epstein-Barr virus. Clin. Diagn. Lab. Immunol. 5:1998;91-97.
19. Kallin B., Luka J., Klein G. Immunochemical characterization of Epstein-Barr virus-associated early and late antigens in n-butyrate-treated P3HR-1 cells. J. Virol. 32:1979;710-716.
20. Lidin B., Gartland L., Marshall G., Sanchez V., Lamon E.W. Detection of two early gene products of Epstein-Barr virus by fluorescence flow cytometry. Viral Immunol. 6:1993;97-107.
21. Lucht E., Biberfeld P., Linde A. Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. J. Infect. 31:1995;189-194.
22. Luka J., Kallin B., Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 94:1979;228-231.
23. Miller G., Niederman J.C., Andrews L.-L. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. New Engl. J. Med. 288:1973;229-232.
24. Murphy S.E., Heiblum R., Trushin N. Comparative metabolism of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus. Cancer Res. 50:1990;4685-4691.
25. Murrah V.A., Gilchrist E.P., Moyer M.P. Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg. Oral Med. Oral Pathol. 75:1993;323-332.
26. Murrah V.A., Gilchrist E.P., Moyer M.P. Attenuation of the natural course of herpes simplex virus infection in human oral epithelial cell cultures by smokeless tobacco extracts suggests the possibility of a synergistic mechanism for carcinogenesis. Oral Surg. Oral Med. Oral Pathol. Oral Rad. Endod. 81:1996;63-69.
27. Niederman J.C., Miller G., Pearson H.A., Pagano J.S., Dowaliby J.M. Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. New Engl. J. Med. 294:1976;1355-1359.
28. Nonoyama M., Pagano J.S. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat. New Biol. 238:1972;169-171.
29. Nutter L.M., Grill S.P., Li J.S., Tan R.S., Cheng Y.C. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells. Cancer Res. 47:1987;4407-4412.
30. Obi F.O., Billett M.A. Preferential binding of the carcinogen benzo[a]pyrene to proteins of the nuclear matrix. Carcinogenesis. 12:1991;481-486.
31. Ooka T., Lenoir G.M., Decaussin G., Bornkamm G.W., Daillie J. Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells. J. Virol. 58:1986;671-675.
32. Park N.H., Dokko H., Li S.L., Cherrick H.M. Synergism of herpes simplex virus and tobacco-specific N′-nitrosamines in cell transformation. J. Oral Maxillofac. Surg. 49:1991;276-281.
33. Pritchett R., Pendersen M., Kieff E. Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Virology. 74:1976;227-231.
34. Pulvertaft R.J.V. A study of malignant tumours in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:1965;261-273.
35. Raab-Traub N. Epstein-Barr virus: the virus and its tumorigenicity in the normal and immunocompromised host. Baillière's Clin. Infect. Dis. 3:1996;457-475.
36. Sairenji T., Spiro R.C., Humphreys R.E. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line. Hematol. Oncol. 2:1984;381-389.
37. Sciubba J., Brandsma J., Schwartz M., Barrezueta N. Hairy leukoplakia: an AIDS-associated opportunistic infection. Oral Surg. Oral Med. Oral Pathol. 67:1989;404-410.
38. Tan R.S., Li J.S., Grill S.P., Nutter L.M., Cheng Y.C. Demonstration of Epstein-Barr virus-specific DNA polymerase in chemically induced Raji cells and its antibody in serum from patients with nasopharyngeal carcinoma. Cancer Res. 46:1986;5024-5028.
39. zur Hausen H., O'Neill F.J., Freese U.K., Hecker E. Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 272:1978;373-375.